4//SEC Filing
Wijkstrom Joakim 4
Accession 0001209191-23-047056
CIK 0001347178other
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 4:23 PM ET
Size
5.1 KB
Accession
0001209191-23-047056
Insider Transaction Report
Form 4
Wijkstrom Joakim
SVP, Chief Marketing Officer
Transactions
- Sale
Common Stock
2023-08-21$5.84/sh−3,724$21,748→ 113,816 total
Footnotes (1)
- [F1]Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001785888
Filing Metadata
- Form type
- 4
- Filed
- Aug 22, 8:00 PM ET
- Accepted
- Aug 23, 4:23 PM ET
- Size
- 5.1 KB